USA 100 , 1220112206 (2003)
For cytosolic folate variables and methionine cycle variables, see the discussions in our previous papers [1621]
The compound remains available through research chemical suppliers and peptide vendors for research purposes
Zhai, T., Li, S., Hu, W., Li, D
The primary endpoint for the EMA was the percentage of patients achieving a SALT 10 at week 24, and the key secondary endpoint was improvement in the Patient's Global Impression of Change (PGI-C), defined as a rating of moderately improved or much improved at week 24 (PGI-C: a 7-point patient scale ranging from very much improved to very much worse).8 Baseline demographic and disease characteristics were balanced among treatment groups: 15% of patients were adolescents, 62% were women, 68% were White, and 46% had AT or AU